Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study). [electronic resource]
Producer: 20071206Description: 1273-80 p. digitalISSN:- 0721-832X
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- adverse effects
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Bevacizumab
- Choroidal Neovascularization -- diagnosis
- Drug Therapy, Combination
- Feasibility Studies
- Female
- Fluorescein Angiography
- Humans
- Injections
- Macular Degeneration -- complications
- Male
- Photochemotherapy
- Photosensitizing Agents -- adverse effects
- Porphyrins -- adverse effects
- Prospective Studies
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Verteporfin
- Visual Acuity
- Vitreous Body
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.